tradingkey.logo
tradingkey.logo
검색

Revvity Inc

RVTY
관심 목록에 추가
113.520USD
+7.890+7.47%
시장 운영 시간 ET시세는 15분 지연됩니다
12.75B시가총액
54.52P/E TTM

자세한 내용은 Revvity Inc 회사

Revvity, Inc. is a provider of health science solutions, technologies, expertise and services that deliver complete workflows from discovery to development, and diagnosis to cure. The Company has specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics and more. Its segments include Life Sciences and Diagnostics. The Life Sciences segment provides products and services targeted towards the life sciences market. The segment offers instruments, reagents, software, detection and imaging technologies, and others. The Diagnostics segment develops diagnostics, tools, and applications focused on clinically oriented customers, within the reproductive health, immunodiagnostics, and applied genomics markets. The segment offers instruments, reagents, assay platforms and software to hospitals, medical labs, clinicians and medical research professionals to help improve the health of families.

Revvity Inc 정보

종목 코드 RVTY
회사 이름Revvity Inc
상장일Aug 12, 2101
CEOSingh (Prahlad R)
직원 수11000
유형Ordinary Share
회계 연도 종료Aug 12
주소77 4Th Avenue
도시WALTHAM
증권 거래소NASDAQ OMX NASDAQ Basic NYSE
국가United States of America
우편 번호02451
전화17816636900
웹사이트https://www.revvity.com/
종목 코드 RVTY
상장일Aug 12, 2101
CEOSingh (Prahlad R)

Revvity Inc의 회사 임원진

이름
이름/직위
직위
주식 보유
변동
Dr. Prahlad R. Singh, Ph.D.
Dr. Prahlad R. Singh, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
113.31K
+14.54%
Mr. Alexandros P. (Alexis) Michas
Mr. Alexandros P. (Alexis) Michas
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
63.77K
+4.21%
Mr. Joel S. Goldberg
Mr. Joel S. Goldberg
Senior Vice President - Administration, General Counsel, Secretary
Senior Vice President - Administration, General Counsel, Secretary
41.51K
+9.21%
Dr. Peter Barrett, Ph.D.
Dr. Peter Barrett, Ph.D.
Independent Director
Independent Director
28.29K
+8.06%
Ms. Miriame Victor
Ms. Miriame Victor
Chief Commercial Officer, Senior Vice President
Chief Commercial Officer, Senior Vice President
18.12K
+21.16%
Mr. Maxwell Krakowiak
Mr. Maxwell Krakowiak
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
16.41K
-38.94%
Ms. Pascale Witz
Ms. Pascale Witz
Independent Director
Independent Director
15.98K
+14.26%
Mr. Tajinder S. Vohra
Mr. Tajinder S. Vohra
Senior Vice President - Global Operations
Senior Vice President - Global Operations
13.96K
+25.23%
Mr. Michael A. Klobuchar
Mr. Michael A. Klobuchar
Independent Director
Independent Director
7.37K
+30.94%
Dr. Sophie V. Vandebroek, Ph.D.
Dr. Sophie V. Vandebroek, Ph.D.
Independent Director
Independent Director
7.37K
+30.94%
더 보기
이름
이름/직위
직위
주식 보유
변동
Dr. Prahlad R. Singh, Ph.D.
Dr. Prahlad R. Singh, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
113.31K
+14.54%
Mr. Alexandros P. (Alexis) Michas
Mr. Alexandros P. (Alexis) Michas
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
63.77K
+4.21%
Mr. Joel S. Goldberg
Mr. Joel S. Goldberg
Senior Vice President - Administration, General Counsel, Secretary
Senior Vice President - Administration, General Counsel, Secretary
41.51K
+9.21%
Dr. Peter Barrett, Ph.D.
Dr. Peter Barrett, Ph.D.
Independent Director
Independent Director
28.29K
+8.06%
Ms. Miriame Victor
Ms. Miriame Victor
Chief Commercial Officer, Senior Vice President
Chief Commercial Officer, Senior Vice President
18.12K
+21.16%
Mr. Maxwell Krakowiak
Mr. Maxwell Krakowiak
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
16.41K
-38.94%

자주 묻는 질문

Revvity Inc의 상위 5대 주주는 누구인가요?

Revvity Inc의 상위 5대 주주는 다음과 같습니다: Dr. Prahlad R. Singh, Ph.D.

Revvity Inc(RVTY)의 주식을 보유한 기관은 몇 개입니까?

2026Q1 기준으로, Revvity Inc의 주식을 보유한 기관은 총 1187곳이며, 이들이 보유한 주식의 총 가치는 약 116.42M로 전체 발행 주식의 104.13%를 차지합니다. 이는 2025Q4 대비 -12219072.00 증가한 수치입니다.
KeyAI